View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
ABGSC Capital Goods Research ... (+3)
  • ABGSC Capital Goods Research
  • Anders Idborg
  • Karl Bokvist
Martin Arnell
  • Martin Arnell

Betsson (Buy, TP: SEK180.00) - Latin America the main attraction

We reiterate our BUY, and have raised our target price to SEK180 (175) after increasing our 2024–2025e EBIT by 1–3%. Latin America continued to surprise on the upside, and upcoming Brazilian regulation presents an interesting growth opportunity. We find the valuation attractive (trading at a 2025e FCF yield of 13% and P/E of 7x) in light of a 2023–2026e EBIT CAGR of 14% with a positive earnings revisions trend.

Delphine Brault ... (+2)
  • Delphine Brault
  • Quentin Borie

Metso : La progression et la résilience de la marge valident le potent...

>T3 2024 : un CA inférieur aux attentes compensé par la marge - Metso a publié hier matin ses résultats T3 2024 (voir first take) qui étaient globalement en ligne avec les attentes, avec un CA légèrement inférieur aux attentes, compensé par une forte progression de la marge.Les prises de commandes étaient en croissance organique de 6% (css à 6.4%) et le CA en recul de 9% en organique (css à -6.1%). La marge d’EBITA ajusté a atteint 16.9% (css à 16.1%), soit une p...

Delphine Brault ... (+2)
  • Delphine Brault
  • Quentin Borie

Metso : Margin growth and resilience validate improvement potential

>Q3 2024: weaker-than-expected revenues offset by the margin - Yesterday morning, Metso reported Q3 2024 results (see First Take published Thursday, 24 October) broadly in line with expectations, with revenues a shade below forecasts, offset by robust margin growth.The order intake was up 6% organically (consensus at 6.4%), while revenues were down 9% organically (consensus at -6.1%). The adjusted EBITA margin reached 16.9% (consensus at 16.1%), +80bp y-o-y....

ABGSC Capital Goods Research ... (+3)
  • ABGSC Capital Goods Research
  • Anders Idborg
  • Karl Bokvist
Delphine Brault ... (+2)
  • Delphine Brault
  • Quentin Borie

Metso : Q3 in line with expectations, with strong margin improvement

>Q3 2024: sales miss (-9% vs -6%) compensated by margin (16.9% vs 16.1%) - Metso this morning reported Q3 2024 results that were slightly below expectations at the order level.The order intake was € 1,226m (consensus € 1,272m), up 6% on an organic basis (consensus 6.4%). Orders were up 9% org. in Minerals (strong activity in copper/gold during the quarter, although rebuild and modernisation service orders were still affected by slow decision-making: equipment +1...

Delphine Brault ... (+2)
  • Delphine Brault
  • Quentin Borie

Metso : Q3 in line with expectations, with strong margin improvement

>Q3 2024: sales miss (-9% vs -6%) compensated by margin (16.9% vs 16.1%) - Metso this morning reported Q3 2024 results that were slightly below expectations at the order level.The order intake was € 1,226m (consensus € 1,272m), up 6% on an organic basis (consensus 6.4%). Orders were up 9% org. in Minerals (strong activity in copper/gold during the quarter, although rebuild and modernisation service orders were still affected by slow decision-making: equipment +1...

ABGSC Capital Goods Research ... (+3)
  • ABGSC Capital Goods Research
  • Anders Idborg
  • Karl Bokvist
ABGSC Capital Goods Research ... (+3)
  • ABGSC Capital Goods Research
  • Anders Idborg
  • Karl Bokvist
Delphine Brault ... (+2)
  • Delphine Brault
  • Quentin Borie

ODDO : Q3 2024 preview: good order levels expected in Q3 and China rai...

>Still healthy commodities prices and demand that could accelerate if Chinese recovery materialises - In Q3, the trends remained broadly unchanged with demand stable at a high level in the mining sector, and limited demand in the construction sector (continuation – and end – of destocking by distributors and core demand still lacklustre in the short term, particularly in Europe). Detailed previews on page 2.The main commodities prices have held up relatively well...

Delphine Brault ... (+2)
  • Delphine Brault
  • Quentin Borie

ODDO : Preview T3 2024 : le bon niveau de commandes attendues au T3 et...

>Des cours de matières premières toujours bien orientés et une demande qui pourrait accélérer si le rebond chinois se matérialise - Lors du T3, les tendances sont restées globalement inchangées avec une demande stable sur des niveaux élevés sur le secteur minier, et une faible demande sur le secteur de la construction (poursuite – et fin – du déstockage des distributeurs et demande sous-jacente toujours mal orientée à CT, notamment en Europe). Previews détaillés en pa...

Bruno Cavalier ... (+3)
  • Bruno Cavalier
  • Jean Danjou
  • Thomas Zlowodzki

ODDO BHF SECURITIES MORNING NEWS – DETAILED COMMENTS 10/14/2024

We are removing GSK from our European Large Caps Convictions List. The company is the only one of the six Big Pharma groups to have experienced a break in trend, which could act as a drag on future publications. Our analyst adjusted this morning his EPS estimates for 2024/2025/2026 by -0.6%, 2.0% and- 3.4% respectively, factoring in weaker growth for Arexvy and Shingrix, hence the lowering of his target price from 2,150p to 1,900p. - ...

Bruno Cavalier ... (+3)
  • Bruno Cavalier
  • Jean Danjou
  • Thomas Zlowodzki

ODDO BHF SECURITIES MORNING NEWS – COMMENTAIRES DETAILLES 14/10/2024

Nous sortons GSK de notre liste de valeurs recommandées Large Caps. La société est la seule des 6 big Pharma à connaître une rupture de tendance qui pourrait peser lors des prochaines publications. Notre analyste ajuste ce jour ses prévisions de BPA 24/25/26 de -0.6%/-2.0%/-3.4% intégrant une plus faible croissance pour Arexvy et Shingrix, ce qui conduit à une baisse de son objectif de cours de 2 150p à 1 900p. - ...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch